Glenmark receives tentative ANDA approval for Saxagliptin
It is the generic version of Onglyza Tablets, 2.5 mg and 5 mg of AstraZeneca
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
IIL to expand its protozoan Vaccine portfolio
It aims to control haemoprotozoan diseases to prevent loss of productivity in cattle.
Sun Pharma receives US FDA approval for ezetimibe
The generic ezetimibe tablets are therapeutic equivalents of Merck’s Zetia tablets
OPPI hosted its sixth Healthcare Access Summit
The summit focussed on bringing policies into best practices in NCDs’ and was supported by MoH&FW, DoP, Ministry of Chemicals…
Ecron Acunova to offer end-to-end capabilities as ‘Navitas Life Sciences’
Navitas Life Sciences will consolidate capabilities of Ecron Acunova, Navitas and Intelent
Mylan and Biocon present clinical data on Insulin Glargine at ADA
Data shows comparable efficacy, safety and immunogenicity to Lantus in Type I and Type II Diabetes Patients
Ozone Pharma introduces DFO 4X Gel
The brand also launched a campaign in May, 2017, named, Dard Baanton Nahi, Mitao, addressing the consumers common pain points
Aptar Pharma extends its CR nasal pump manufacturing capabilities in North America
Aptar Pharma’s Child-Resistant Feature for nasal sprays combines Child-Resistance (CR) and Senior-Friendliness (SF) with its…
COPD market set to hit $14.1 billion by 2025: GlobalData
This steady growth will be driven by factors including an increase in diagnosed prevalent cases and the entry of new…
TLLLF appoints Kiran Mazumdar-Shaw, CMD, Biocon, as trustee
Mazumdar-Shaw intends to help with greater government engagement in order to shape policy around mental health in India
Biocon shareholders approve issue of bonus shares
The bonus shares were approved by way of capitalisation of reserves
Strides Shasun gets USFDA approval for Parkinsons drug
The product will be launched immediately
Waters collaborates with Wyatt
R&D scientists will receive higher quality information and data 5x faster than ever before
Unichem Laboratories gets EIR for Ghaziabad formulation unit
The receipt indicates the successful closure of the inspection and the queries raised during the audit
Zydus Cadila gets USFDA nod for mesalamine tablets
The company will manufacture the product at its Moraiya facility in Ahmedabad
Natco plans to launch 8-10 branded formulations this year
The company also plans to expand its Hepatitis-C product
Alembic Pharma looks to file 100 ANDAs in US in next three years
The company aims to launch up to 12 products per year in the US during this time
DRL launches Bivalirudin injection in US market
The injection in 250 mg/vial are available in packages of 10 single-dose vials
Cadila Pharmaceuticals plants 2000 saplings to celebrate ‘World Environment Day’
2000 saplings were planted at facilities located in Jammu, Bhat, Kadi, Hirapur, Dholka and Ankleshwar
Zydus Cadila gets US FDA nod for anti depressant
The company will manufacture the product at its facility in Baddi